Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies. | Cancer Immunol Immunother | 2024 | 38231412 | PubTator, text mining | PubMed |
| Designed allosteric protein logic. | Cell Discov | 2024 | 38228615 | PubTator, text mining | PubMed |
| CAR T cells for hematological malignancies. | J Clin Invest | 2024 | 38226627 | PubTator, text mining | PubMed |
| Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancy. | Nat Commun | 2024 | 38225288 | PubTator, text mining | PubMed |
| CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia. | Mediterr J Hematol Infect Dis | 2024 | 38223477 | PubTator, text mining | PubMed |
| SPC25 as a novel therapeutic and prognostic biomarker and its association with glycolysis, ferroptosis and ceRNA in lung adenocarcinoma. | Aging (Albany NY) | 2024 | 38217547 | PubTator, text mining | PubMed |
| Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies. | J Biomed Sci | 2024 | 38217016 | PubTator, text mining | PubMed |
| Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma. | Virol J | 2024 | 38216938 | PubTator, text mining | PubMed |
| TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy. | J Immunother Cancer | 2024 | 38212124 | PubTator, text mining | PubMed |
| The Mechanisms of Altered Blood-Brain Barrier Permeability in CD19 CAR T-Cell Recipients. | Int J Mol Sci | 2024 | 38203814 | PubTator, text mining | PubMed |
| Endogenous Signaling Molecule Activating (ESMA) CARs: A Novel CAR Design Showing a Favorable Risk to Potency Ratio for the Treatment of Triple Negative Breast Cancer. | Int J Mol Sci | 2024 | 38203786 | PubTator, text mining | PubMed |
| Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. | Int J Mol Sci | 2024 | 38203757 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence. | Cells | 2024 | 38201305 | PubTator, text mining | PubMed |
| Evolution of cell therapy for renal cell carcinoma. | Mol Cancer | 2024 | 38195534 | PubTator, text mining | PubMed |
| Increased cysteinyl-tRNA synthetase drives neuroinflammation in Alzheimer's disease. | Transl Neurodegener | 2024 | 38191451 | PubTator, text mining | PubMed |
| Myeloid leukemia-derived galectin-1 downregulates CAR expression to hinder cytotoxicity of CAR T cells. | J Transl Med | 2024 | 38184596 | PubTator, text mining | PubMed |
| Author Correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape. | Nat Med | 2024 | 38182787 | PubTator, text mining | PubMed |
| Tuning spacer length improves the functionality of the nanobody-based VEGFR2 CAR T cell. | BMC Biotechnol | 2024 | 38178096 | PubTator, text mining | PubMed |
| Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications. | Exp Mol Med | 2024 | 38172594 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T-cell therapy-induced nervous system toxicity: a real-world study based on the FDA Adverse Event Reporting System database. | BMC Cancer | 2024 | 38166723 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=10